23.5 C
New York
Tuesday, May 21, 2024
HomeMarkets
Markets

Oculus CEO Says Company Continues to Generate New Revenues by Partnering and Launching More FDA Cleared Products Despite Doubters

By Insider Scoop
0
25
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Hoji Alimi, founder and CEO of Oculus Innovative Sciences, Inc. (NASDAQ: OCLS), in an exclusive, candid interview with BioMedReports, answers questions about whether his company will ever become a profitable and successfully commercialized biotechnology firm.

In addition to drastically reducing its burn rate from over $18 million a year in 2008 to roughly $3 million for the first nine months of the current fiscal year, Alimi says his firm is significantly close to EBITDAS breakeven in September of 2011 with trailing revenues 2011 of $12.1 million. At this point, speculators are wondering whether Oculus is a good rebound play or whether the bears will continue to cast doubt on any bullish opportunities hinted at for the firm’s banged up share price by its CEO.

(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.


For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,183FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x